Aggregated data for 1 documents

ERBB4 Mutation Analysis: Emerging Molecular Target for Melanoma Treatment [2016. Christopher Lau, Keith J. Killian, Yardena Samuels, and Udo Rudloff] https://t.co/jZT2W8k9uu

A different kind of handbook: https://t.co/gyRTWhe4bt

Can anyone access this paper? Quantitative & Spatial Image Analysis of Tumor and Draining Lymph.. Peter Lee #paywall http://t.co/w3AYMAwInY

"Pathological staging of melanoma (review)," Methods Mol Biol > http://t.co/Ead8oYjpij

"Lymphatic Invasion as a Prognostic Biomarker in Primary Cutaneous Melanoma," Methods Mol Biol > http://t.co/H65z5mUyfw

Targeting Damage-Associated Molecular Pattern Molecules (DAMPs) and DAMP Receptors in Melanoma http://t.co/ZkjCNnzaWA

Immunologic Monitoring of Cancer Vaccine Trials Using the ELISPOT Assay http://t.co/zJJQHe00vy

Tumor-infiltrating lymphocytes and their significance in melanoma prognosis. http://t.co/qsYnSV9AvL

Current status of diagnostic and prognostic markers in melanoma. http://t.co/QibjkcJazq

Immune system functional pathway analysis using single cell network profiling (SCNP): a novel tool in cancer... http://t.co/pkaOXWJGRL

@estherCE2010 http://t.co/X7rgTPdTgO

New MD Anderson publication: 'Tissue resources for clinical use and marker studies in #melanoma': MethodsMolBiol http://t.co/m7VwHYyita

Immunologic Monitoring of Cancer Vaccine Trials Using the ELISPOT Assay. http://t.co/W4KmQAMji0

Selecting Patients for KIT Inhibition in Melanoma. http://t.co/zpBoUv8F5j

Novel insights/translational implication from the emerging biology of melanoma. http://t.co/madCa8tEew

Markers for Anti-cytotoxic T-lymphocyte Antigen 4 (CTLA-4) Therapy in Melanoma. http://t.co/QbBJWvujm9

Marker utility for combination therapy. http://t.co/Bqrk1XZyx5

Immunologic Monitoring of Cancer Vaccine Trials Using the ELISPOT Assay. http://t.co/W4KmQAMji0

Emerging clinical issues in melanoma in the molecularly targeted era. http://t.co/x1dB4jkMhs

Detection of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Melanoma. http://t.co/dhLZfgrALj

Construction & analysis of multiparameter prognostic models for melanoma outcome. http://t.co/wm0Qnzxtsm

Clinical, pathologic, & imaging features & biological markers of uveal melanoma. http://t.co/SR7YDg49Iz

B7-h abnormalities in melanoma & clinical relevance. http://t.co/7PidYmfZ4p

Advances in adjuvant therapy: potential for prognostic & predictive biomarkers. http://t.co/SsnqLEZ8aj

Chromosomal copy number analysis in melanoma diagnostics. http://t.co/1abCQ33VQX

Tumor-infiltrating lymphocytes & their significance in melanoma prognosis. http://t.co/xysNLuQ1JU

Tissue resources for clinical use & marker studies in melanoma. http://t.co/BRsw3Ftm1x

The Clinical Use of PET/CT in the Evaluation of Melanoma. http://t.co/jCBM692SEC

Targeting Damage-Associated Molecular Pattern Molecules (DAMPs) & DAMP Receptors in Melanoma. http://t.co/hAWKRpNxdl

Pathological staging of melanoma. http://t.co/oNxSd78Who

Molecular karyotyping for detection of prognostic markers in fine needle aspiration biopsy samples of uveal... http://t.co/AxZcacXSjt

Melanoma susceptibility genes & risk assessment. http://t.co/nC8GhF3xxC

Lymphatic invasion as a prognostic biomarker in primary cutaneous melanoma. http://t.co/2Rcjv835VJ

Isolation of melanoma cell subpopulations using negative selection. http://t.co/mEAsrTWAUJ

Isolation of Circulating MicroRNAs from Microvesicles Found in Human Plasma. http://t.co/V06sKz3YX7

Immunohistochemical diagnostic & prognostic markers for melanoma. http://t.co/5dPbYKlGoZ

Epigenetic markers of prognosis in melanoma. http://t.co/oXw5zwhhIN

Detection of circulating tumor cells by photoacoustic flowmetry. http://t.co/kZJYEs4YyY

Detection of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Melanoma. http://t.co/dhLZfgrALj

Current status of diagnostic & prognostic markers in melanoma. http://t.co/MWluubEow9

Construction & analysis of multiparameter prognostic models for melanoma outcome. http://t.co/wm0Qnzxtsm

Clinical, pathologic, & imaging features & biological markers of uveal melanoma. http://t.co/SR7YDg49Iz

Circulating tumor cells as prognostic biomarkers in cutaneous melanoma patients. http://t.co/MA0uaouoV8

Chromosomal copy number analysis in melanoma diagnostics. http://t.co/1abCQ33VQX

A prognostic test to predict the risk of metastasis in uveal melanoma based on a 15-gene expression profile. http://t.co/qjsA2BOhgT

Integrating Molecular Biomarkers into Current Clinical Management in Melanoma. http://t.co/Nx5oXd9AeE

ERBB4 Mutation Analysis: Emerging Molecular Target for Melanoma Tx. http://t.co/lVKRfSU0Ge

Detecting Mechanisms of Acquired BRAF Inhibitor Resistance in Melanoma. http://t.co/12ahtClDB3

Assaying for BRAF V600E in Tissue & Blood in Melanoma. http://t.co/Okegb0rcqf

Tumor-Infiltrating Lymphocytes and Their Significance in Melanoma Prognosis. http://t.co/vUw0C9N2q9

Current Status of Diagnostic and Prognostic Markers in Melanoma. http://t.co/UCxNKdmtCg